Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteins.
about
5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.Cloning, expression, purification, and characterization of LC-1 ScFv with GFP tagThe efficacy of NP11-4-derived immunotoxin scFv-artesunate in reducing hepatic fibrosis induced by Schistosoma japonicum in miceAdoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model.In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.
P2860
Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteins.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Targeting immune effector mole ...... specific scFv fusion proteins.
@en
type
label
Targeting immune effector mole ...... specific scFv fusion proteins.
@en
prefLabel
Targeting immune effector mole ...... specific scFv fusion proteins.
@en
P2093
P2860
P356
P1433
P1476
Targeting immune effector mole ...... specific scFv fusion proteins.
@en
P2093
David M Shaw
Kevin A Myers
M Jim Embleton
Matthew G Ryan
Miles W Carroll
Peter L Stern
Susan M Kingsman
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700513
P50
P577
2002-11-01T00:00:00Z
P5875
P6179
1033406657